Philip Morris International (PM)

Regulatory News:

Philip Morris International Inc. (PMI) (NYSEPM) marks the 10th anniversary of the introduction of its leading smoke-free product, IQOS. The launch of this smoke-free innovation was a breakthrough moment toward achieving the company’s commitment to a future without cigarettes.

The U.S. Food and Drug Administration (FDA) authorized a renewal of a risk modification order submitted by Swedish Match USA, Inc. (Swedish Match), an affiliate of Philip Morris International, Inc. (PMI) (NYSEPM), for eight General snus products. As part of the authorization, the agency granted use of the modified risk claim to reach more adults 21+ who smoke or use traditional tobacco products. The agency concluded that renewing the General snus risk modification order will significantly reduce harm and the risk of tobacco-related disease to individual tobacco users and benefit the health of the population as a whole.

Regulatory News:

WASHINGTON - Oct. 8, 2024 - PRLog -- International trade law firm Jacobson Burton Kelley PLLC (JBK) is pleased to announce the addition of Jorge Vera, an experienced international trade and sanctions attorney, as Of Counsel in the Washington, DC office. Jorge brings a wealth of experience from his previous role as Senior Counsel for Trade and Sanctions at The Boeing Company and his co-leadership of the trade group at the Saudi Arabian Oil Company (Aramco).At JBK Jorge will collaborate with the firm's attorneys to advise U.S. and international companies and financial institutions on a wide range of matters, including international trade, sanctions compliance, transactional issues, and enforcement."Jorge's extensive background in both international law firms and in-house counsel roles uniquely positions him to provide our clients with sound, practical, and actionable advice," said Doug Jacobson, the firm's managing partner. "His expertise in commercial and defense issues, sanctions matters, CFIUS, and national security affairs makes him a versatile and invaluable addition to our team."With over a decade of experience in international trade, sanctions, and policy, Jorge has an impressive career trajectory. He began working at the Western Hemisphere office of the United States Trade Representative and served as an analyst at Philip Morris International, supporting the government affairs group. As a Michael Gadbaw Fellow in International Law & Policy at General Electric, Jorge honed his skills further. He has also worked as a consultant at a big four consulting firm, developing trade compliance plans, processes, and procedures for clients, and auditing entities under consent agreements."Jorge will significantly enhance our capability to navigate the increasingly complex and evolving trade and sanctions regulations for our diverse clientele," said partner Glen Kelley.Michael Burton echoed these sentiments, stating, "Jorge's ability to work across various industries and roles makes him a valuable member of our firm. He understands the nuances of small, medium, and large enterprises and excels in working with clients worldwide. Our clients will find Jorge to be a capable and effective advisor who is a pleasure to work with."Doug Jacobson expressed his enthusiasm, saying, "I have known Jorge for many years and am pleased to welcome him to our firm. With our combined expertise, we are even better equipped to provide our clients with efficient and cost-effective solutions to their most complex sanctions and export compliance issues. Jorge's background in consulting, big law, and corporate environments, along with his language skills, will complement our existing capabilities in global trade and sanctions, allowing us to reach clients in even more parts of the world."About Jacobson Burton Kelley PLLCWith offices in Washington, DC and New York, New York, Jacobson Burton Kelley PLLC advises U.S. and non-U.S. companies on a wide variety of international trade issues, including compliance, investigations and audits, enforcement, and transactional matters. The firm's practice areas include sanctions and export controls, customs, anti-bribery and anti-money laundering law, and US foreign investment review (CFIUS).JBK attorneys are ranked in the leading international attorney guides, including Chambers and Partners and Who's Who Legal. Jacobson Burton Kelley PLLC is a member of the Trusted Trade Alliance and has strategic alliance with MME, a Switzerland-based law and consulting firm, and with Bennink Dunnin-Wasowicz, a law firm based in the Netherlands and France. JBK has been recognized by the publication WorldECR as one of the leading export controls law firms in the United States.Jacobson Burton Kelley PLLCInternational Trade Law1725 I Street, NW, Suite 300Washington, DC 20006Tel: 202.431.2407info@jacobsonburton.comwww.jbktradelaw.com

Regulatory News:

Regulatory News:

Investors need to keep growth and income top of mind for their portfolios as lower interest rates work their way through the financial markets

Stocks priced under $1 provide an affordable entry for investors aiming for high potential returns. These five emerging companies show strong growth potential, and with market trends favoring undervalued sectors, they are worth considering now.

Vectura Fertin Pharma, Inc., an affiliate of Philip Morris International Inc. (PMI) (NYSEPM), today announces the sale of its subsidiary Vectura Group Ltd. (Vectura) to Molex Asia Holdings Ltd., and the establishment of master service agreements to develop Vectura Fertin Pharma’s inhaled therapeutics proprietary pipeline. Vectura will be operated by Phillips Medisize, a Molex company. The sale includes upfront cash consideration of GBP 150 million, subject to customary purchase price adjustments, and potential deferred payments of up to GBP 148 million. The transaction is subject to customary closing conditions, including regulatory approval.

Cardiol Therapeutics (NASDAQCRDL) recently showcased its groundbreaking Myocarditis treatment, CardiolRx™, on Fox Business's Making Money with Charles Payne, highlighting the potential life-saving impact of this innovative therapy.

Regulatory News:

These five stocks are generating significant attention and could offer strong opportunities for growth across sectors like biotech, tech, energy, and medical devices.

Philip Morris International Inc. (PMI) (NYSEPM) today warns about the high levels of contraband and counterfeit cigarettes in the European Union (EU) year over year, with 35.2 billion illicit cigarettes consumed in the region in 2023, accounting for 8.3% of total consumption in the EU, an increase of 0.1 percentage point compared to 2022.

Here are five companies in the spotlight, under $5 across technology, biomedical, healthcare, aerospace, commercial real estate and medical sectors, demonstrating strong market trends, volume, and awareness:

Regulatory News:

Regulatory News:

Philip Morris International Inc. (PMI) (NYSEPM) is announcing an investment of $232 million through one of its Swedish Match affiliates to expand production capacity of its manufacturing facility in Owensboro, Ky. The expansion is expected to create an additional 450 direct jobs with an ongoing annual economic impact of $277 million and an additional 410 indirect jobs* for the commonwealth of Kentucky. The facility produces ZYN nicotine pouches to help meet the growing demand from legal-age consumers switching from cigarettes or other traditional tobacco products.

The companies featured in this article demonstrate strong market potential and innovation-driven growth. With strategic moves and robust fundamentals, these stocks offer attractive opportunities for investors seeking to capitalize on emerging trends and market dynamics. Currently rebounding from their 52-week lows, these stocks present excellent opportunities for portfolio diversification.

Altria Group's shares fell after it missed EPS and revenue estimates. It increased nicotine pouch market share but not by much considering ZYN shortages.

Regulatory News:

Regulatory News:

Regulatory News:

Today, Philip Morris International Inc. (PMI) (NYSEPM) announced an investment of $600 million over the next two years through one of its U.S. affiliates to open a state-of-the-art manufacturing facility in Aurora, Colo. The facility is expected to create 500 direct jobs with ongoing annual economic impact of $550 million and an additional 1,000 indirect jobs* for the State of Colorado as it produces Swedish Match ZYN nicotine pouches to help meet the growing global demand from legal-age consumers for smoke-free products.

Experts from Swedish Match USA, Inc., an affiliate of Philip Morris International Inc. (NYSEPM) (PMI), presented to the Tobacco Products Scientific Advisory Committee (TPSAC) on June 26, 2024. The committee, comprised of independent scientific researchers, provides regulatory guidance to the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products.